Is your child wheezing or coughing more than usual or complaining of a tight chest during play? It may just be a cough or a sniffle, or it could mark the onset of childhood asthma. How can you be sure? And what would having asthma mean for your child’s day-to-day life?
First, if your child is diagnosed with asthma, please remember that you’re not alone. Asthma is one of the most common chronic diseases affecting children. Nearly 10 per cent of children living in a European Union country have been diagnosed with some form of asthma. Although asthma is classified as a chronic disease, in most cases it can be kept very well in check.
Asthma is a condition that causes airways to narrow and swell and produce extra mucus when exposed to what are known asthma triggers – breathing infections like a common cold, contact with various allergens like dust, pollen or pet hair, exercise, inhaling cold air or even air pollution.
Because children have smaller airways than adults, even small amounts of swelling can block the flow of air making breathing difficult. And, of course, children can’t easily tell us what they are feeling, so they should be monitored carefully for symptoms.
Some parents worry that if their asthmatic child becomes too emotional, it will trigger an attack. But there’s little formal research to support this and with a daily asthma medication plan, there’s no reason your child can’t safely experience the whole range of childhood emotions, and even fast running games. In fact, the better fitness a child can get through exercise, the better asthma control they will have.
Childhood asthma can be managed with a regular controller medication – typically inhaled steroids. Rescue medication with inhaled bronchodilators helps to ease the symptoms.
If play is the work of childhood, then all children should be able to participate to the fullest. A correct diagnosis combined with the right asthma plan can make the difference for your child between being a spectator or an active partaker of all the fun and games of a good childhood.
By Laurel Colless
Photo by iStock
|If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Health Products Regulatory Authority (HPRA) website: www.hpra.ie or email email@example.com|
Date of preparation: January 2021 / EASYH-1198(1)
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being for more than 100 years. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. Respiratory diseases are one of Orion’s core therapy areas. Orion's net sales in 2018 amounted to EUR 977 million and the company had about 3,200 employees. Orion's A and B shares are listed on Nasdaq Helsinki.®
As a forward-looking pharmaceutical company, Orion continues to invest in research and development of treatment options for people with asthma and COPD. The focus is on safety and quality in each step of the product life cycle while taking care of the environment. Sustainability is entwined in the whole process from R&D through manufacturing. It is also required of Orion’s providers. Orion is committed to keeping the best possible control of the environmental impacts of their own factories by reducing energy consumption and the impact of their waste waters, among others, and is making good progress in that regard. Orion works to ensure that suppliers have procedures in place to control and reduce their own environmental impacts as well. All aspects of sustainability - social, economic and environmental - are carefully considered in the whole product life cycle, including patient use and the disposal of old inhalers.